Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Net Margin (2016 - 2025)

Dare Bioscience's Net Margin history spans 9 years, with the latest figure at 143.72% for Q4 2025.

  • For Q4 2025, Net Margin fell 860948.0% year-over-year to 143.72%; the TTM value through Dec 2025 reached 1313.32%, up 23961564.0%, while the annual FY2025 figure was 1300.66%, 4013024.0% up from the prior year.
  • Net Margin reached 143.72% in Q4 2025 per DARE's latest filing, up from 162340.76% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 18079.54% in Q2 2025 to a low of 162340.76% in Q3 2025.
  • Average Net Margin over 4 years is 24095.04%, with a median of 829.91% recorded in 2023.
  • The largest YoY upside for Net Margin was 5087866bps in 2025 against a maximum downside of -15111208bps in 2025.
  • A 4-year view of Net Margin shows it stood at 3.84% in 2022, then crashed by -7379bps to 279.75% in 2023, then skyrocketed by 3126bps to 8465.75% in 2024, then plummeted by -102bps to 143.72% in 2025.
  • Per Business Quant, the three most recent readings for DARE's Net Margin are 143.72% (Q4 2025), 162340.76% (Q3 2025), and 18079.54% (Q2 2025).